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Escherichia coli RNA polymerase and the endogenous engaged RNA polymerase I were used as specific 
probes to monitor the physiologically inactive and active nucleolar chromatin template function, 
respectively. Actinomycin D bound preferentially tothe physiologically active regions of rat liver nucleolar 
Actinomycin 
1. INTRODUCTION 
chromatin in vivo. 
D Chemical carcinogen Nucleolar chromatin Nucleolar DNA 
RNA polymerase I RNA polymerase, of E. coli 
Actinomycin D, a widely used chemotherapeutic 
agent [l] and also a carcinogen [2], is a potent in- 
hibitor of DNA-dependent RNA synthesis [3,4]. 
The mechanism of actinomycin D-binding to DNA 
is well studied [5,6], it is clear that with the natur- 
ally occurring DNA duplex, deoxyguanosine 
residues in the DNA are important for the binding. 
Since the distribution of deoxyguanosine residues 
in a given cellular DNA is quite general, it is believ- 
ed that the interaction of actinomycin D with the 
DNA is non-selective. However, under normal 
physiological conditions in vivo, DNA is complex- 
ed with chromosomal proteins and organized into 
transcriptionally active and inactive chromatin 
[7,8]. The question is whether actinomycin D in- 
teracts randomly or selectively with chromatin 
under these physiological conditions in vivo. To 
answer this question specific probes are needed. 
RNA polymerase of Escherichia coli could 
transcribe mammalian chromatin, but at random 
sites [9- 111. This bacterial enzyme can transcribe 
the physiologically inactive regions of rat liver 
nucleolar chromatin [12]. The endogenous engag- 
ed RNA polymerase I [ 13,141 transcribes only the 
physiologically active nucleolar chromatin coding 
for ribosomal RNA [10,15,16]. Thus, these two en- 
zymes, one of which transcribes chromatin ran- 
domly and the other transcribes only the active 
genes, may be used as specific probes to monitor 
the binding of chemical carcinogens to chromatin 
whether it is random or selective. This paper 
reports that actinomycin D binds preferentially to 
the physiologically active regions of rat liver 
nucleolar chromatin in vivo. 
2. MATERIALS AND METHODS 
2.1. Actinomycin D administration in vivo 
Male Sprague-Dawley rats (-200 g body wt.) 
were divided into groups of 3 animals. Ac- 
tinomycin D (0.5 mg/ml HzO) was injected in- 
traperitoneally at doses of 50, 100, 250, 500 and 
1000 pg/lOO g body wt, and the animals were km- 
ed 30 min later. 
2.2. Isolation of rat liver nucleoli, nucleolar DNA 
and RNA polymerase I
The procedure was as in [ 17. 
2.3. Assay of rat liver nucleolar chromatin 
template function with endogenous-engaged 
RNA polymerase I and E. coli RNA poly- 
merase after actinomycin D administratian 
in vivo 
The assay conditions for RNA polymerase ac- 
tivities were essentially the same as in [ 171. Briefly, 
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Fig.I. Effect of actinomycin D administered in vivo on rat liver nucleolar chromatin template function measured with 
the endog~ous~ngaged RNA polymerase I and RNA polymerase of E. coii. Male Sprague-Dawley rats (-200 g body 
wt) were divided into groups of 3 animals. Actinomycin D at doses of 50, 100, 250, 500 and lOOO~g/lOO g body wt 
was given intraperitoneally 30 min before sacrificing. Liver nucleoli were isolated as in 1171. The template fficiency 
of nuckolar chromatin (10-15 /rg DNA) in supporting RNA synthesis was measured at37°C for 20 min under standard 
RNA assay conditions [17] in the absence or presence of 3 units of RNA polyrnerase of E. coli (Worthington). Net E. 
coli RNA polymerase activity (m) is calculated by subtracting the corresponding endogenous-engaged RNA polymerase 
I activity (0) from each group. Control values (180%) for RNA polymerase I and RNA polymerase of E. co& activities 
were 10345 and 17704 pmof [“HJGMP ~co~rat~/~ DNA, respectively. Data presented are average values from 3 
separate xpt. 
the assay was carried out in vitro with 0.2 ml stan- 
dard assay medium (medium A) containing: 
100 mM of Tris-HCI (pH 7.9 at 23”C), 2 mM 
MnClt, 28 mM 2-mercaptoeth~ol, 70 mM 
(NH&SO4, and 0.2 mM each of ATP, GTP, UTP 
and CTP with 4 &i [8-3H]GTP (Amersham; spec. 
act. lo-20 CVmmol). The reaction was initiated 
by the addition of 0.1 ml nucledar suspension 
from either control or actinomycin D-treated 
sources (fig.1) and in the absence or presence of 3 
units of RNA polymerase of E. coli (holoenzyme, 
Wo~~n~on). The reaction mixture was incubated 
at 37°C for 20 min with shaking. All the assays 
were stopped by transfer of the reaction tubes (12 
x 75 mm) to chipped ice, followed by immediate 
addition of 5 ml cold 10% trichloroacetic acid con- 
taming 1% sodium pyrophosphate. The acid- 
insoluble material was collected on Whatman 
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GF/C filters and washed 74imes with 5 ml 5% 
cold trichloroacetic acid containing 1% sodium 
pyrophosphate, and twice with 5 ml 60% ethanol. 
The filters were air-dried in liquid scintillation vials 
and the radioactivity was counted in 5 ml Bray’s 
solution [ 181. The specific activity of RNA 
polymerase was expressed as pmol [‘H]GMP in- 
corporated/mg DNA. DNA concentrations were 
determined as in [19]. 
2.4. Assay of rat liver nucleolar chromatin 
template function with endogenous engaged 
RNA polymerase I and RNA polymerase of 
E. coli after actinomycin D-binding 
in vitro 
The activities of RNA polymerase were assayed 
the same way as above except that actinomycin D 
at various concentrations (fig.2) was added to the 
0.2 ml medium A at zero time in the absence or 
presence of 3 units of RNA polymerase of E. coli. 
RNA synthesis was assayed at 37°C for 20 min. 
The assays were stopped, radioactive samples were 
processed and counted as above. 
2.5. Assay of purified rat liver nucleolar DNA 
template function with solubilized RNA po&- 
merase I and RNA polymerase of E. coli 
in the presence of actinomycin D
Actinomycin D at the concentrations indicated 
(fig.3) was added to 0.2 ml medium A containing 
3 pg purified nucleolar DNA at zero time, and the 
DNA template function was measured separately 
for RNA synthesis at 37OC for 20 min under stan- 
dard RNA assay conditions as above, with either 3 
units of RNA polymerase of E. coli or solubilized 
RNA polymerase I. 
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Fig.2. Effect of actinomyein D added in vitro on rat liver nucleolar chromatin template function measured with the 
endogenous-engaged RNA polymerase I and RNA polymerase of E. coli. Rat liver nucleoli were isolated as in 1171. 
Actinomycin D at the concentrations indicated was added to nucleolar suspensions (10-15 pg DNA) at zero time, and 
the chromatin template function was measured for RNA synthesis at 37°C for 20 min under standard RNA May 
conditions [17] in the absence or presence of 3 units of RNA polymerase of E. cofi as in fig.1. (m) RNA polymerase 
activity of E. cofi; (0) endogenous-engaged RNA polymerase I activity. Control values (100%) for RNA polymenase 
I and RNA polymerase of E. coli activities were 13 360 and 12 778 pmol [‘H]GMP incorporated/mg DNA, respectively. 
Data presented are average values from 2 separate expt. 
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3. RESULTS AND DISCUSSION 
Fig.1 shows that when rats were given in- 
traperitoneal injections of actinomycin D at 
5~l~~g/l~ g body wt 30 min prior to 
sacrifice, the endogenous-engaged RNA 
polymerase I activity (O-G) is rapidly inhibited. 
At SOfig a~nomycin D this i~ibition is 80%; at 
2 100 fig the inhibition is >90%. On the other 
hand, transcription of nucleolar chromatin by 
RNA polymerase ofE. coil (a-a) is not inhibited 
at 50 /rg actinomycin D and only 20% inhibition at 
1OOpg. Even at lOOO/cg the nucleolar chromatin 
template still retains close to ~0~0 of its original 
capacity for RNA polymerase of E. coli transcrip- 
tion. Since the in~bition of the engaged RNA 
polymerase I activity represents he binding of ac- 
tinomycin D to the active nucleolar chromatin 
[10,15,16], and the inhibition of RNA polymerase 
of E. coli reflects the non-selective binding of ac- 
tinomycin D to the general nucleolar chromate 
[g-12], these data suggest that at low concentra- 
tions actinomycin D binds preferentially tothe ac- 
tive regions of the nucleolar chromatin. At higher 
concentrations, it starts to bind the inactive regions 
of the nucleolar chromatin as the preferred binding 
sites in the active regions become saturated. 
However, these data alone do not rule out the 
possibility that the binding of actinomycin D still 
could be random if RNA polymerase of E. coli 
were intrinsically insensitive to actinomycin D 
inhibition. 
We next investigated the binding property of ac- 
tinomycin D when it was added in vitro to the 
isolated rat liver nucleoli. Fig.2 shows there is still 
a differential inhibtion of the endogenous engaged 
RNA polymerase I activity (Q-O) over that of 
the RNA polymerase activity of E. coli (D-CI) 
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Fig. 3. Effect of actinomycin D added in vitro on rat liver nucleolar DNA template function measured with solubilized- 
engaged RNA polymerase I and RNA polymerase of E. coli. Rat liver nucleolar DNA was isolated as in 11% 
A~inomy~in D at the ~on~ntrations indicated was added to nucleolar DNA (3 pg) sus~nsions at zero time, and the 
DNA template function was measured separately for RNA synthesis at 37°C for 20 min under standard RNA assay 
conditions with either 3 units of RNA polymerase of E. coli or solubilized RNA polymerase I. (I) RNA polymerase 
activity of E. coli; (0) solubilized RNA polymerase I activity. Control values (lOO@i’o) for RNA polymerase I and RNA 
polymerase of E. coli activities were 7608 and 453500 pmol [3H]GMP ~co~rated/mg DNA, respectively. Data 
presented are average values from 2 separate xpt. 
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over 0.001 ,ug-5 pg/ml. For example, at 0.1 pg/ml 
of actinomycin D, RNA polymerase I activity is in- 
hibited 46Q0, while RNA polymerase activity of E. 
coli is inhibited only 14%. At 0.5 /rg/ml, there is 
90% inhibition of RNA polymerase I activity, and 
only 44% inhibition of E. coli enzyme activity. 
These data indicate that although the binding 
selectivity is not as marked as with in vivo ad- 
ministration of actinomycin D (fig.l), there is still 
a preferred binding by actinomycin D to the 
physiologically active regions of the nucleolar 
chromatin. Again, RNA polymerase of E. cofi may 
be intrinsically less sensitive to actinomycin D 
inhibition. 
The evidence that RNA polymerase of E. coli is 
equally sensitive to actinomycin D inhibition as 
RNA polymerase I is provided by the use of 
purified nucleolar DNA. Fig.3 shows that when ac- 
tinomycin D at 0.001-5 /cg/ml is added to purified 
rat liver nucleolar DNA, the activities of both 
enzymes are now equally inhibited by actino- 
mycin D throughout the concentrations tested. 
Thus, the data shown in fig.1 are true indications 
that actinomycin D binds preferentially to the 
physiologically active regions of nucleolar 
chromatin in vivo, and that this binding specificity 
is partially lost when actinomycin D is added to the 
isolated nucleoli in vitro (fig.2). 
This result is similar to preferential DNase I 
digestion at the active genes of nucleolar 
chromatin [ 12,20-231. It also supports the concept 
[7] that chromosomal proteins are important 
regulatory elements conferring additional features 
that distinguish the active genes from the inactive 
ones. 
This simple method could be used to study the 
binding specificity of various chromatin- or DNA- 
reacting agents; e.g., nucleases, hormones and 
chemical carcinogens. Using this method we have 
shown [24] that aflatoxin Bi also preferentially 
binds to the physiologically active regions of 
nucleolar chromatin in vivo. 
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